Da An Gene Co Ltd of Sun Yat-Sen University Cash Flow Conversion Efficiency
Da An Gene Co Ltd of Sun Yat-Sen University cash flow conversion efficiency. Based on the latest financial reports, Da An Gene Co Ltd of Sun Yat-Sen University (002030) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥111.80 Million ≈ $16.36 Million USD) by net assets (CN¥7.99 Billion ≈ $1.17 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Da An Gene Co Ltd of Sun Yat-Sen University (2002–2025)
Cash flow conversion efficiency of Da An Gene Co Ltd of Sun Yat-Sen University from 2002 to 2025. This chart illustrates how Da An Gene Co Ltd of Sun Yat-Sen University's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002030 stock price for real-time trading data and today's change.
Da An Gene Co Ltd of Sun Yat-Sen University Cash Flow Conversion Ratio Explained
Da An Gene Co Ltd of Sun Yat-Sen University cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Da An Gene Co Ltd of Sun Yat-Sen University Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Da An Gene Co Ltd of Sun Yat-Sen University ranked by their cash flow conversion efficiency. Also see 002030 company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangzhou Lingwe Technology Co. Ltd. A
SHE:301373
|
N/A |
|
Meitav Dash Investments Ltd
TA:MTDS
|
0.074x |
|
OCI Co Ltd
KO:010060
|
0.034x |
|
Tips Music Limited
NSE:TIPSMUSIC
|
0.178x |
|
Wenzhou Yihua Connector Co Ltd
SHE:002897
|
-0.029x |
|
BlackRock Health Sciences Trust II
NYSE:BMEZ
|
0.103x |
|
Elbit Systems Ltd
TA:ESLT
|
0.081x |
|
AXWAY SOFTWARE EO 2
F:1XV
|
N/A |
Annual Cash Flow Conversion Efficiency for Da An Gene Co Ltd of Sun Yat-Sen University (2002–2025)
The table below shows the annual cash flow conversion efficiency of Da An Gene Co Ltd of Sun Yat-Sen University from 2002 to 2025. Review 002030 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥7.36 Billion ≈ $1.08 Billion |
CN¥319.49 Million ≈ $46.75 Million |
0.043x | +17.62% |
| 2024-12-31 | CN¥8.14 Billion ≈ $1.19 Billion |
CN¥300.33 Million ≈ $43.95 Million |
0.037x | -60.07% |
| 2023-12-31 | CN¥9.16 Billion ≈ $1.34 Billion |
CN¥845.76 Million ≈ $123.76 Million |
0.092x | -74.18% |
| 2022-12-31 | CN¥11.62 Billion ≈ $1.70 Billion |
CN¥4.15 Billion ≈ $607.99 Million |
0.358x | -17.09% |
| 2021-12-31 | CN¥7.66 Billion ≈ $1.12 Billion |
CN¥3.30 Billion ≈ $483.56 Million |
0.431x | -22.54% |
| 2020-12-31 | CN¥4.51 Billion ≈ $660.64 Million |
CN¥2.51 Billion ≈ $367.95 Million |
0.557x | +1150.55% |
| 2019-12-31 | CN¥2.09 Billion ≈ $305.47 Million |
CN¥92.97 Million ≈ $13.60 Million |
0.045x | -75.02% |
| 2018-12-31 | CN¥2.20 Billion ≈ $322.01 Million |
CN¥392.38 Million ≈ $57.42 Million |
0.178x | +314.17% |
| 2017-12-31 | CN¥2.64 Billion ≈ $386.56 Million |
CN¥-219.93 Million ≈ $-32.18 Million |
-0.083x | +44.25% |
| 2016-12-31 | CN¥2.55 Billion ≈ $373.61 Million |
CN¥-381.28 Million ≈ $-55.79 Million |
-0.149x | -4908.78% |
| 2015-12-31 | CN¥1.94 Billion ≈ $283.84 Million |
CN¥-5.78 Million ≈ $-846.26K |
-0.003x | -106.75% |
| 2014-12-31 | CN¥914.64 Million ≈ $133.84 Million |
CN¥40.38 Million ≈ $5.91 Million |
0.044x | +24.06% |
| 2013-12-31 | CN¥758.10 Million ≈ $110.93 Million |
CN¥26.98 Million ≈ $3.95 Million |
0.036x | +560.85% |
| 2012-12-31 | CN¥626.21 Million ≈ $91.63 Million |
CN¥3.37 Million ≈ $493.43K |
0.005x | -95.38% |
| 2011-12-31 | CN¥554.12 Million ≈ $81.09 Million |
CN¥64.54 Million ≈ $9.44 Million |
0.116x | -28.88% |
| 2010-12-31 | CN¥482.34 Million ≈ $70.58 Million |
CN¥78.99 Million ≈ $11.56 Million |
0.164x | +29.14% |
| 2009-12-31 | CN¥428.60 Million ≈ $62.72 Million |
CN¥54.35 Million ≈ $7.95 Million |
0.127x | +68.67% |
| 2008-12-31 | CN¥385.31 Million ≈ $56.38 Million |
CN¥28.97 Million ≈ $4.24 Million |
0.075x | +164.42% |
| 2007-12-31 | CN¥309.15 Million ≈ $45.24 Million |
CN¥8.79 Million ≈ $1.29 Million |
0.028x | -73.47% |
| 2006-12-31 | CN¥280.69 Million ≈ $41.07 Million |
CN¥30.09 Million ≈ $4.40 Million |
0.107x | +3.99% |
| 2005-12-31 | CN¥269.70 Million ≈ $39.47 Million |
CN¥27.80 Million ≈ $4.07 Million |
0.103x | +70.61% |
| 2004-12-31 | CN¥256.72 Million ≈ $37.57 Million |
CN¥15.51 Million ≈ $2.27 Million |
0.060x | -75.73% |
| 2003-12-31 | CN¥92.08 Million ≈ $13.47 Million |
CN¥22.92 Million ≈ $3.35 Million |
0.249x | +40.25% |
| 2002-12-31 | CN¥69.03 Million ≈ $10.10 Million |
CN¥12.25 Million ≈ $1.79 Million |
0.177x | -- |
About Da An Gene Co Ltd of Sun Yat-Sen University
Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers PCR testing kits, including hepatitis virus, human papillomavirus (HPV), sexually transmitted infections … Read more